Use of (18)F-FDG PET/CT to locate primary malignancies in patients with hepatic cirrhosis and malignant ascites.

TitleUse of (18)F-FDG PET/CT to locate primary malignancies in patients with hepatic cirrhosis and malignant ascites.
Publication TypeJournal Article
Year of Publication2013
AuthorsFan H-B, Wang A-J, Yang D-L, Xiao J, Ai Y, Huang L, Guo Y, Zhou M-X, Wu J-J, Li Z, Yan F-M, Wang Y-M
JournalChinese journal of cancer research = Chung-kuo yen cheng yen chiu
Volume25
Issue5
Pagination500-4
Date Published2013 Oct
Abstract

Ascites in patients with hepatic cirrhosis is caused by cirrhosis in most cases. For most malignant ascites, the primary malignancy could be readily identified using conventional imaging methods, e.g., computed tomography (CT) and magnetic resonance imaging (MRI). However, in a small fraction of the patients, the primary malignancy remains occult even with these examinations. In this retrospective study, we assessed the usefulness of (18)F-FDG PET/CT in patients with hepatic cirrhosis and malignant ascites of otherwise unknown origin.

DOI10.2147/CLEP.S53009
Alternate JournalChin. J. Cancer Res.